Tag: biomedical
-
Trial Begins Testing Digital Therapy for Anxiety with Lung Disease
A clinical trial is underway testing a mobile app designed to help people with a serious lung disorder manage anxiety that often accompanies the disease.
-
Infographic – Higher HIV Burden for Women, Girls in Africa
The data show falling numbers of young men and women in sub-Saharan Africa with new HIV infections since 2010, but the percentage of infected women and girls also rising over that time.
-
Trial Shows Fast-Absorbing Opioid Overdose Nasal Swab
Results of a clinical trial show a nasal swab dispensing an opioid antidote transfers more of the antidote into the blood stream than syringe injections or nasal sprays.
-
Virtual Pathology Image Company Opens, Raises $15.2M
A developer of virtual tissue staining systems aided by algorithms for medical images began public operations today, raising $15.2 million in venture funds.
-
Sustained-Released Eye Treatment Company Raises $11.9M
A company creating extended-release delivery techniques for eye therapies is raising $11.9 million in its first venture funding round.
-
Trial Shows Insulin Capsules Reduce Blood Glucose Levels
Results of a clinical trial reveal an optimal dose for an insulin capsule that in 12 weeks reduces blood glucose levels in patients with type 2 diabetes.
-
FDA Clears Digital Health Monitoring System
A developer of remote health tracking technology says the Food and Drug Administration cleared its continuous patient monitoring system for clinical use.
-
Biomarker-Guided Depression Drug Trial Underway
The first participant in a clinical trial received an experimental drug to treat patients with depression that express high levels of a stress-related protein.
-
Grant Funds Implanted Brain-Computer Spinal Injury Device
A project to develop a brain-computer device to stimulate upper and lower limb movement in people with spinal cord injuries is receiving a €3.7 million award.
-
Infographic – U.S. Dominates Diabetes Drug Sales
More than 133 million people have diabetes, nearly one-third of the world’s total, yet almost half of the world’s diabetes drug sales volume is in the U.S.